08.22.17
Clorox sold the Aplicare skin antisepsis business to Medline Industries, a leading privately-held manufacturer and distributor of health care supplies in the US. The transaction closed on Aug. 21. A purchase price was not disclosed. Aplicare had $46 million in net sales.
"Selling Aplicare, which was part of our professional products business, was the result of our periodic strategic assessment of our global portfolio," said Clorox Chairman and CEO Benno Dorer. "We are very pleased that, in Medline, we've found a buyer that has strong capabilities and can add significant value to the Aplicare business."
Dorer added, "Importantly, this doesn't change the strategic focus of our professional products business, which continues to be stopping the spread of infection, with an emphasis on killing pathogens in the environment."
"Selling Aplicare, which was part of our professional products business, was the result of our periodic strategic assessment of our global portfolio," said Clorox Chairman and CEO Benno Dorer. "We are very pleased that, in Medline, we've found a buyer that has strong capabilities and can add significant value to the Aplicare business."
Dorer added, "Importantly, this doesn't change the strategic focus of our professional products business, which continues to be stopping the spread of infection, with an emphasis on killing pathogens in the environment."